Literature DB >> 6526052

Comparison between visual assessment and quantitative measurement of radioactivity on the bone scintigram in Paget's disease of bone.

C J Vellenga, E K Pauwels, O L Bijvoet.   

Abstract

Two methods of evaluating bone scintigrams in Paget's disease of bone were compared. Bone scintigraphy was performed after IV injection of 20 mCi 99mTc-Sn-EHDP. Qualitative evaluation was carried out by visual assessment of the photographs of the oscilloscope of the gamma camera, using a scale of six well-defined scores. Quantitative evaluation of uptake of radionuclide was obtained by calculating the ratio of the number of counts per pixel in pagetoid bone with that in comparable normal bone; measurements were performed by a computer interfaced to the gamma camera, after marking the regions of interest with a light-pen. In 42 patients with untreated Paget's disease there was a linear relationship between the visually assessed score and the logarithm of the computer-measured ratio. In 27 patients treated with APD a decrease in uptake was measured in all lesions and was usually also detected visually; however, in 14% of these lesions the changes (ranging from 9% to 70%) were not visible to the eye. Here too, visual estimation of the changes corresponded to the logarithm of the measured changes. In conclusion, there is a semilogarithmic relationship between the visual and the physical methods.

Entities:  

Mesh:

Year:  1984        PMID: 6526052     DOI: 10.1007/bf00256850

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  18 in total

1.  A radioisotopic method of evaluating the response to Calcitonin therapy in Paget's disease.

Authors:  G de Rossi; C Focacci; F Greco; L de Palma; A Catino
Journal:  Radiol Diagn (Berl)       Date:  1977

2.  Radiographs and scans in diagnosing symptomatic lesions of Paget's disease of bone (osteitis deformans).

Authors:  M R Khairi; J A Robb; H N Wellman; C C Johnston
Journal:  Geriatrics       Date:  1974-12

3.  Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.).

Authors:  W B Frijlink; O L Bijvoet; J te Velde; G Heynen
Journal:  Lancet       Date:  1979-04-14       Impact factor: 79.321

4.  Radionuclide uptake studies of bone: a quantitative method of evaluating the response of patients with Paget's disease to diphosphonate therapy.

Authors:  A B Goldman; P Braunstein; D Wilkinson; S Kammerman
Journal:  Radiology       Date:  1975-11       Impact factor: 11.105

5.  Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone.

Authors:  G Heynen; P Delwaide; O L Bijvoet; P Franchimont
Journal:  Eur J Clin Invest       Date:  1982-02       Impact factor: 4.686

6.  [Bone scintigraphy in Paget's disease].

Authors:  B Mazières; M Jung-Rosenfarb; G Bouteiller; A Fournie; J Arlet
Journal:  Rev Rhum Mal Osteoartic       Date:  1978-05

7.  Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).

Authors:  R D Altman; C C Johnston; M R Khairi; H Wellman; A N Serafini; R R Sankey
Journal:  N Engl J Med       Date:  1973-12-27       Impact factor: 91.245

8.  Evaluation of 99mTc diphosphonate kinetics and bone scans in patients with Paget's disease before and after calcitonin treatment.

Authors:  A D Waxman; S Ducker; D McKee; J K Siemsen; F R Singer
Journal:  Radiology       Date:  1977-12       Impact factor: 11.105

9.  Diphosphonate treatment of Paget's disease.

Authors:  G A Finerman; H C Gonick; R K Smith; J M Mayfield
Journal:  Clin Orthop Relat Res       Date:  1976-10       Impact factor: 4.176

10.  Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans.

Authors:  I Stein; B Shapiro; B Ostrum; M L Beller
Journal:  Clin Orthop Relat Res       Date:  1977 Jan-Feb       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.